Unmasking EGFR: How Targeted Therapy Gave Natasha a Second Chance
In 2022, Natasha was diagnosed with stage 4 lung cancer in her late 40s—an unexpected twist for a healthy, active mother and teacher. Discover how an EGFR mutation and targeted therapy offered her renewed hope.
Unmasking EGFR: How Targeted Therapy Gave Natasha a Second Chance Read More »